Iterum Therapeutics plc ITRMF

Full chart Compare
Set alert

Price alert · ITRMF

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

0.024 Day range 0.0249
0.00001 52-week range 0.645
YTD
-100.00%
1 year
-100.00%

Revenue & Expenses

Other Income → Expenses: $196.00KExpenses → Selling, General & Admin: $11.28MExpenses → Research & Development: $90.77MExpenses → Interest Expense: $861.00KExpenses → Income Tax: $444.00KGross Profit → Expenses: $37.00KRevenue → Gross Profit: $37.00KNet Loss → Expenses: $103.13MOther Income$196.00KGross Profit$37.00KNet Loss$103.13MExpenses$103.36MSelling, General & Admin$11.28MResearch & Development$90.77MInterest Expense$861.00KIncome Tax$444.00KRevenue$37.00K

Latest period ending Dec 31, 2024 · select a line to chart its full history

Annual income statement

ITRMF annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
254.00K0000
-254.00K0000
18.44M47.47M30.38M24.54M32.13M
10.46M39.99M17.62M10.71M21.07M
7.98M7.48M12.77M13.82M11.05M
-18.70M-47.47M-30.38M-24.54M-32.13M
2.52M1.43M2.36M5.55M15.10M
240.00K613.00K301.00K705.00K743.00K
-24.77M-38.37M-44.43M-91.56M-52.01M
-24.77M-38.37M-44.43M-91.56M-52.01M
-24.77M-38.37M-44.43M-91.56M-52.01M
-24.77M-38.37M-44.43M-91.56M-52.01M
-1.26-2.96-3.63-8.41-32.49
-1.26-2.96-3.63-8.41-32.49
-1.26-2.96-3.63-8.41-32.49
-22.01M-36.33M-41.77M-85.31M-36.17M
-22.01M-36.33M-41.77M-85.31M-36.17M
19.70M12.96M12.24M10.89M1.60M
19.70M12.96M12.24M10.89M1.60M